Medtronic and AGA Settle Patent Dispute

Medtronic Inc. has agreed to settlement of a lawsuit it initiated against AGA Medical Corp. in 2007 for infringement of Medtronic’s Jervis patent family. Under the terms of the settlement, in consideration of AGA’s payments to settle the litigation, Medtronic and AGA will end the litigation and Medtronic will grant a nonexclusive license to AGA to use the Jervis patent family.

April 22, 2010

1 Min Read
Medtronic and AGA Settle Patent Dispute

Patents in the Jervis patent family, the last of which is scheduled to expire in 2018, cover the use of stress to restrain certain self-expanding medical devices made of nitinol. Nitinol is a shape-memory metal alloy frequently used in medical device applications, including Medtronic’s own transcatheter coronary heart valve program. Medtronic has widely licensed the Jervis patent family to medical device manufacturers in the United States and will continue to offer licenses to this important technology.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like